BMS Financial Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,469
Closed -$249K 117
2022
Q4
$249K Sell
1,469
-61
-4% -$11.1K 0.16% 86
2022
Q3
$286K Buy
1,530
+39
+3% +$8.22K 0.2% 91
2022
Q2
$242K Buy
1,491
+80
+6% +$12.7K 0.16% 89
2022
Q1
$265K Buy
1,411
+132
+10% +$25.1K 0.17% 96
2021
Q4
$339K Buy
+1,279
New +$345K 0.22% 82

Other funds holding RGEN

BMS Financial Advisors's RGEN Position: Q1 2023 in Review

BMS Financial Advisors sold out of Repligen (RGEN) in Q1 2023, closing a stake of 1,469 shares — an estimated $249K sold.

BMS Financial Advisors first reported a position in RGEN in Q4 2021 and held it in 5 quarters. The position peaked at $339K in Q4 2021. 446 funds tracked by Wall St. Rank hold RGEN as of Q1 2023.

  • BMS Financial Advisors reported no remaining Repligen position as of Q1 2023 after selling out during the quarter.
  • BMS Financial Advisors sold 1,469 Repligen shares in Q1 2023, an estimated $249K.
  • BMS Financial Advisors first reported a position in Repligen in Q4 2021 and held it in 5 quarters.
  • BMS Financial Advisors's Repligen position peaked at $339K in Q4 2021.
  • 446 funds tracked by Wall St. Rank held Repligen as of Q1 2023.

Based on BMS Financial Advisors's 13F filing for Q1 2023, filed 10 Apr 2023.